Nitsan Halevy

Dr. Nitsan Halevy is the Chief Medical Officer at Pluristem Therapeutics, where she leads clinical and regulatory activities. Nitsan has over 15 years of experience leading global clinical research and drug development programs. From an academic setting at Brigham and Women’s Hospital (Boston), Nitsan transitioned to industry, where she has held roles of increasing responsibility and scope at Novartis, Teva and Quark Pharmaceuticals. She holds an MD from Ben-Gurion University.